TSHA in the 13F filings
Taysha Gene Therapies Inc · CUSIP 877619106
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 4 Aug 2026
- Managers listing it
- 21
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 2 listed it in both
- Shares listed
- 31,663,539
- combined, among listed positions
- Reported value
- $215m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 12 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,078,336.
Managers listing TSHA in Q2 2026
21 of 21 holders
Largest increases and reductions, by shares
Increases
- Wellington Management Group LLPexisting position · 3,975,605 shares now+3,349,244
- Farallon Capital Management LLCnew position · 2,250,000 shares now+2,250,000
- Citadel Advisors LLCexisting position · 1,535,287 shares now+1,124,152
- Holocene Advisors LPnew position · 510,000 shares now+510,000
- Jane Street Group LLCnew position · 228,355 shares now+228,355
Reductions
- Millennium Management LLCexisting position · 2,126,838 shares now-1,154,982
- Fidelity (FMR LLC)existing position · 13,336,413 shares now-984,842
- Two Sigma Investments LPexisting position · 234,716 shares now-507,365
- Invesco Ltdexisting position · 264,379 shares now-103,642
- Susquehanna International Group LLPexisting position · 27,164 shares now-89,133
New positions and exits
New (3)
Exited (5)
- Point72 Asset Management LPwas $2.1m
- Renaissance Technologies LLCwas $1.8m
- Tudor Investment Corpwas $642k
- Hudson Bay Capital Management LPwas $48k
- Quantbot Technologies LPwas $2k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2020 | 1 | $11m | n.a. | n.a. |
| Q4 2020 | 1 | $13m | n.a. | n.a. |
| Q1 2021 | 1 | $10m | n.a. | n.a. |
| Q2 2021 | 1 | $11m | n.a. | n.a. |
| Q3 2021 | 1 | $9.3m | n.a. | n.a. |
| Q4 2021 | 1 | $5.8m | n.a. | n.a. |
| Q1 2022 | 1 | $3.3m | n.a. | n.a. |
| Q2 2022 | 1 | $1.9m | n.a. | n.a. |
| Q3 2022 | 1 | $965k | n.a. | n.a. |
| Q4 2022 | 1 | $3.4m | n.a. | n.a. |
| Q1 2023 | 1 | $1.2m | n.a. | n.a. |
| Q2 2023 | 1 | $992k | n.a. | n.a. |
| Q3 2023 | 1 | $4.7m | n.a. | n.a. |
| Q4 2023 | 1 | $6.5m | 1 | 0 |
| Q1 2024 | 2 | $11m | 1 | 0 |
| Q2 2024 | 2 | $11m | 1 | 0 |
| Q3 2024 | 2 | $9.5m | 1 | 0 |
| Q4 2024 | 1 | $6.4m | 0 | 0 |
| Q1 2025 | 1 | $5.1m | 0 | 0 |
| Q2 2025 | 1 | $9.5m | 1 | 0 |
| Q3 2025 | 2 | $36m | 1 | 1 |
| Q4 2025 | 1 | $861k | 15 | 6 |
| Q1 2026 | 2 | $2.9m | 16 | 8 |
| Q2 2026 | 4 | $25m | 12 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TSHA and GILD →TSHA and AMGN →TSHA and ARGX →Choose a stock to compare with TSHA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TSHA, latest filings →Back to the 13F Explorer →